A drug previously used to treat psoriasis has shown positive results in a phase II trial assessing its effectiveness at treating type 1 diabetes, according to a study published in The Lancet Diabetes and Endocrinology. The drug, alefacept, is an immune-suppressing drug that has been used to treat psoriasis, a common skin condition, for around a decade. According to the team of US researchers, there have been trials in the 1980s and 1990s that explored the use of immune-suppressing drugs to treat type 1 diabetes...
via Health News from Medical News Today Read More Here..
No comments:
Post a Comment